IF by specialty › Rheumatology
Advances in Rheumatology — Impact Factor
The 2025 Impact Factor of Advances in Rheumatology is 2.8 (Q2 in Rheumatology; fully open access).
- Impact Factor
- 2.8 JCR 2025
- JCR category
- Rheumatology
- Quartile
- Q2 in Rheumatology
- Publisher
- Springer Nature (BMC)
- Open access
- fully open access
- IF source
- –
Position within the field
Ranked 24 of the 33 journals in Rheumatology on this site (bottom 50%).
Rheumatology journals with a similar Impact Factor
- Rheumatology and Therapy IF 3.1
- BMC Rheumatology IF 3.1
- Osteoarthritis and Cartilage Open IF 2.9
- ACR Open Rheumatology IF 2.9
- Rheumatology Advances in Practice IF 2.8
- Clinical Rheumatology IF 2.7
About this value
The Journal Impact Factor of Advances in Rheumatology (JCR 2025, released June 2026) is 2.8. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Rheumatology.